{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:02:49Z","timestamp":1779339769313,"version":"3.51.4"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.prostaglandins.2016.04.006","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T11:35:12Z","timestamp":1462707312000},"page":"63-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Epoxyeicosatrienoic acids (EETs) form adducts with DNA in vitro"],"prefix":"10.1016","volume":"123","author":[{"given":"Dorothee J.","family":"Funk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd L.","family":"Sorg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Kopka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz H.","family":"Schmeiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2016.04.006_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-2275(20)32049-6","article-title":"Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of arachidonic acid monooxygenases","volume":"41","author":"Capdevila","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2016.04.006_bib0010","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0022-2275(20)32202-1","article-title":"A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol","volume":"39","author":"Fulton","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2016.04.006_bib0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/em.20547","article-title":"32P-postlabelling analysis of DNA adducts formed by leukotriene A4 (LTA4)","volume":"51","author":"Funk","year":"2010","journal-title":"Environ. Mol. Mutagen."},{"issue":"11:2","key":"10.1016\/j.prostaglandins.2016.04.006_bib0020","first-page":"5656","article-title":"Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen: DNA adducts","volume":"45","author":"Gupta","year":"1985","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.prostaglandins.2016.04.006_bib0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1021\/tx034018+","article-title":"Covalent binding of leukotriene A4 to DNA and RNA","volume":"16","author":"Hankin","year":"2003","journal-title":"Chem. Res. Toxicol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2016.04.006_bib0030","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/nprot.2007.394","article-title":"The 32P-postlabeling assay for DNA adducts","volume":"2","author":"Phillips","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.prostaglandins.2016.04.006_bib0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.plipres.2013.11.003","article-title":"Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer","volume":"53","author":"Zhang","year":"2014","journal-title":"Prog. Lipid Res."}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316300144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316300144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T08:18:26Z","timestamp":1718525906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882316300144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":7,"alternative-id":["S1098882316300144"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.04.006","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epoxyeicosatrienoic acids (EETs) form adducts with DNA in vitro","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}